World's Best Scientists 2026 revealed!
Award Badge
Medicine
Taiwan
2026

D-Index & Metrics

Medicine

D-Index
127
Citations
65369
World Ranking
2813
National Ranking
6

Research.com Recognitions

  • 2026 - Research.com Medicine in Taiwan Leader Award
  • 2025 - Research.com Medicine in Taiwan Leader Award
  • 2023 - Research.com Medicine in Taiwan Leader Award
  • 2022 - Research.com Medicine in Taiwan Leader Award
  • 2011 - Fellow, The World Academy of Sciences

Overview

Pei-Jer Chen is affiliated with National Taiwan University in Taiwan and has contributed extensively to the field of medicine, with a particular focus on epidemiology, hepatology, molecular biology, infectious diseases, and oncology. Their research spans a wide range of topics including hepatitis B virus studies, hepatitis C virus research, liver disease diagnosis and treatment, hepatocellular carcinoma treatment and prognosis, SARS-CoV-2 and COVID-19 research, renal diseases and glomerulopathies, and hepatitis viruses studies and epidemiology.

Frequent coauthors in Pei-Jer Chen's work include Chun-Jen Liu, Jia-Horng Kao, Tung-Hung Su, Chen-Hua Liu, and Tai-Chung Tseng. This network indicates an active collaboration within the scientific community, particularly in areas related to viral hepatitis and liver diseases.

Publications by Pei-Jer Chen have appeared predominantly in the following venues:

  • Journal of the Formosan Medical Association
  • Journal of Hepatology
  • PubMed
  • bioRxiv (Cold Spring Harbor Laboratory)
  • Hepatology International

Key recent papers from Pei-Jer Chen include:

  • Furin Inhibitors Block SARS-CoV-2 Spike Protein Cleavage to Suppress Virus Production and Cytopathic Effects (2020, Cell Reports)
  • The Origin and Underlying Driving Forces of the SARS-CoV-2 Outbreak (2020, Journal of Biomedical Science)
  • 2020 Taiwan Consensus Statement on the Management of Hepatitis C: Part (II) Special Populations (2020, Journal of the Formosan Medical Association)
  • Permanent Inactivation of HBV Genomes by CRISPR/Cas9-Mediated Non-cleavage Base Editing (2020, Molecular Therapy - Nucleic Acids)
  • 2020 Taiwan Consensus Statement on the Management of Hepatitis C: Part (I) General Population (2020, Journal of the Formosan Medical Association)

Pei-Jer Chen's research prominently addresses viral infections and associated liver conditions. Much of the work focuses on hepatitis B and C viruses, with implications for the diagnosis, treatment, and management of liver diseases including hepatocellular carcinoma. Their research on SARS-CoV-2 aligns with the global scientific efforts during the COVID-19 pandemic to understand viral mechanisms and develop therapeutic strategies.

In recognition of their scientific contributions, Pei-Jer Chen was named a Fellow of The World Academy of Sciences in 2011. Continued publication activity and collaboration reflect an ongoing involvement in advancing medical knowledge, especially within their primary institutional affiliation in Taiwan.

Best Publications

  • Asian-Pacific clinical practice guidelines on the management of hepatitis B: a 2015 update.

    S. K. Sarin;M. Kumar;G. K. Lau;Z. Abbas

  • Asia–Pacific clinical practice guidelines on the management of hepatocellular carcinoma: a 2017 update

    Masao Omata;Ann Lii Cheng;Norihiro Kokudo;Masatoshi Kudo

  • Hepatitis B e antigen and the risk of hepatocellular carcinoma.

    Hwai I. Yang;Sheng Nan Lu;Yun Fan Liaw;San Lin You

  • Hepatitis B genotypes correlate with clinical outcomes in patients with chronic hepatitis B

    Jia-Horng Kao;Pei-Jer Chen;Ming-Yang Lai;§ Ding-Shinn Chen‡

  • Asian Pacific Association for the Study of the Liver consensus recommendations on hepatocellular carcinoma.

    Masao Omata;Laurentius A. Lesmana;Ryosuke Tateishi;Pei Jer Chen

  • Global patterns of hepatocellular carcinoma management from diagnosis to death: The BRIDGE Study

    Joong Won Park;Minshan Chen;Massimo Colombo;Lewis Rowland Roberts

  • Hepatitis B Virus Genotype and DNA Level and Hepatocellular Carcinoma: A Prospective Study in Men

    Ming-Whei Yu;Shiou-Hwei Yeh;Pei-Jer Chen;Yun-Fan Liaw

  • Associations Between Hepatitis B Virus Genotype and Mutants and the Risk of Hepatocellular Carcinoma

    Hwai I. Yang;Shiou Hwei Yeh;Pei Jer Chen;Pei Jer Chen;Uchenna H. Iloeje

  • Hepatitis B genotypes and the response to interferon therapy.

    Jia-Horng Kao;Nan-Hui Wu;Pei-Jer Chen;Ming-Yang Lai

  • High Levels of Hepatitis B Surface Antigen Increase Risk of Hepatocellular Carcinoma in Patients With Low HBV Load

    Tai–Chung Tseng;Tai–Chung Tseng;Chun–Jen Liu;Hung–Chih Yang;Tung–Hung Su

  • Basal core promoter mutations of hepatitis B virus increase the risk of hepatocellular carcinoma in hepatitis B carriers.

    Jia–Horng Kao;Pei–Jer Chen;Ming–Yang Lai;Ding–Shinn Chen

  • Risk estimation for hepatocellular carcinoma in chronic hepatitis B (REACH-B): development and validation of a predictive score

    Hwai I. Yang;Hwai I. Yang;Man Fung Yuen;Henry Lik Yuen Chan;Kwang Hyub Han

  • Metabolic factors and risk of hepatocellular carcinoma by chronic hepatitis B/C infection: a follow-up study in Taiwan.

    Chi–Ling Chen;Hwai–I. Yang;Wei–Shiung Yang;Chun–Jen Liu

  • Linifanib Versus Sorafenib in Patients With Advanced Hepatocellular Carcinoma: Results of a Randomized Phase III Trial

    Calin Cainap;Shukui Qin;Wen-Tsung Huang;Ik Joo Chung

  • The present and future disease burden of hepatitis C virus (HCV) infection with today's treatment paradigm.

    A. Sibley;Kwang Hyub Han;A. Abourached;L. A. Lesmana

  • How common is non-alcoholic fatty liver disease in the Asia-Pacific region and are there local differences?

    Deepak N. Amarapurkar;Estsuko Hashimoto;Laurentius M. Adrianto Lesmana;José D. Sollano

  • Relation of an Interleukin-10 Promoter Polymorphism to Graft-versus-Host Disease and Survival after Hematopoietic-Cell Transplantation

    Ming Tseh Lin;Barry Storer;Paul J. Martin;Paul J. Martin;Li Hui Tseng

  • The CRISPR/Cas9 System Facilitates Clearance of the Intrahepatic HBV Templates In Vivo

    Su-Ru Lin;Hung-Chih Yang;Yi-Ting Kuo;Chun-Jen Liu

  • The large form of hepatitis delta antigen is crucial for assembly of hepatitis delta virus.

    Fu-Lin Chang;Pei-Jer Chen;Su-Jen Tu;Chuan-Jen Wang

  • Acute exacerbations of chronic type B hepatitis are accompanied by increased T cell responses to hepatitis B core and e antigens. Implications for hepatitis B e antigen seroconversion.

    S L Tsai;Pei-Jer Chen;M Y Lai;P M Yang

Frequent Co-Authors

Ding-Shinn Chen
Ding-Shinn Chen National Taiwan University
Jia-Horng Kao
Jia-Horng Kao National Taiwan University
Chun-Jen Liu
Chun-Jen Liu National Taiwan University
Ming-Yang Lai
Ming-Yang Lai National Taiwan University
Shiou-Hwei Yeh
Shiou-Hwei Yeh National Taiwan University
Hung-Chih Yang
Hung-Chih Yang National Taiwan University
Ann-Lii Cheng
Ann-Lii Cheng National Taiwan University
Chien-Jen Chen
Chien-Jen Chen Academia Sinica
Mei-Hwei Chang
Mei-Hwei Chang National Taiwan University
Hong-Yuan Hsu
Hong-Yuan Hsu National Taiwan University

If you think any of the details on this page are incorrect, let us know.

Report an issue

We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below:

Related Online Degrees & Career Pathways

If you’re considering studying Medicine in the USA, it’s helpful to explore related healthcare degrees and alternative career pathways. Many students look for flexible options that allow them to start working in healthcare without spending years in medical school.

For those who want a nursing career, you might consider enrolling in the easiest bsn program to get into. These programs typically have more accessible admission requirements, making them a great choice for newcomers. Similarly, there are nursing schools that don't require teas test, saving you the need to prepare for additional entrance exams.

If you’re interested in administrative roles, consider earning an accelerated healthcare administration degree online. This can quickly prepare you for healthcare management and leadership positions.

Lastly, non-clinical careers, such as working in medical records, are also in demand. You can attend medical billing and coding schools online with financial aid to start a career in the fast-growing health information field.

Best Scientists Citing Pei-Jer Chen

Trending Scientists

Recently Published Articles